Trial
NCT06067802
Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Jerry Vockley, MD, PhD
Collaborators
Ultragenyx Pharmaceutical Inc
Condition
Medium-chain Acyl-CoA Dehydrogenase Deficiency
Intervention
Triheptanoin
Why stopped
Funding was pulled
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-07-02